Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Second primary cancers in long-term survivors of glioblastoma.

Kim JY, Jackman JG, Woodring S, McSherry F, Herndon JE, Desjardins A, Friedman HS, Peters KB.

Neurooncol Pract. 2019 Sep;6(5):386-391. doi: 10.1093/nop/npz001. Epub 2019 Feb 4.

PMID:
31555453
2.

Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?

Sarmiento JM, Mukherjee D, Black KL, Fan X, Hu JL, Nuno MA, Patil CG.

J Neurol Surg A Cent Eur Neurosurg. 2016 May;77(3):195-200. doi: 10.1055/s-0035-1566121. Epub 2016 Mar 2.

PMID:
26935296
3.

Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.

Lu J, Cowperthwaite MC, Burnett MG, Shpak M.

PLoS One. 2016 Apr 28;11(4):e0154313. doi: 10.1371/journal.pone.0154313. eCollection 2016.

4.

Distress persists in long-term brain tumor survivors with glioblastoma multiforme.

Keir ST, Farland MM, Lipp ES, Friedman HS.

J Cancer Surviv. 2008 Dec;2(4):269-74. doi: 10.1007/s11764-008-0069-7. Epub 2008 Oct 29.

PMID:
18958627
5.

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.

Michaelsen SR, Urup T, Olsen LR, Broholm H, Lassen U, Poulsen HS.

J Neurooncol. 2018 May;137(3):533-542. doi: 10.1007/s11060-017-2739-7. Epub 2018 Jan 5.

PMID:
29305787
6.

Long-term survival after glioblastoma resection: hope despite poor prognosis factors.

Costa E, Lawson TM, Lelotte J, Fomekong E, Vaz RG, Renard L, Whenham N, Raftopoulos C.

J Neurosurg Sci. 2019 Jun;63(3):251-257. doi: 10.23736/S0390-5616.18.04180-2. Epub 2018 Jan 23.

PMID:
29363298
7.

IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients.

Amelot A, De Cremoux P, Quillien V, Polivka M, Adle-Biassette H, Lehmann-Che J, Françoise L, Carpentier AF, George B, Mandonnet E, Froelich S.

PLoS One. 2015 Jul 9;10(7):e0130596. doi: 10.1371/journal.pone.0130596. eCollection 2015.

8.

A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?

Adeberg S, Bostel T, König L, Welzel T, Debus J, Combs SE.

Radiat Oncol. 2014 Apr 23;9:95. doi: 10.1186/1748-717X-9-95.

9.

Long-term survivors of glioblastoma: a closer look.

Gately L, McLachlan SA, Philip J, Ruben J, Dowling A.

J Neurooncol. 2018 Jan;136(1):155-162. doi: 10.1007/s11060-017-2635-1. Epub 2017 Oct 27.

PMID:
29079955
10.

Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.

Hartmann C, Hentschel B, Simon M, Westphal M, Schackert G, Tonn JC, Loeffler M, Reifenberger G, Pietsch T, von Deimling A, Weller M; German Glioma Network.

Clin Cancer Res. 2013 Sep 15;19(18):5146-57. doi: 10.1158/1078-0432.CCR-13-0017. Epub 2013 Aug 5.

11.

The cohort of long-term survivors at the German childhood cancer registry.

Debling D, Spix C, Blettner M, Michaelis J, Kaatsch P.

Klin Padiatr. 2008 Nov-Dec;220(6):371-7. doi: 10.1055/s-0028-1086027. Epub 2008 Oct 23.

PMID:
18949673
12.

Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.

Paniccia A, Hosokawa P, Henderson W, Schulick RD, Edil BH, McCarter MD, Gajdos C.

JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.

PMID:
26062046
13.
14.

Long-term glioblastoma multiforme survivors: a population-based study.

Scott JN, Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, Sutherland G, Cairncross JG, Forsyth P.

Can J Neurol Sci. 1998 Aug;25(3):197-201.

PMID:
9706720
15.

Molecular profiling of long-term IDH-wildtype glioblastoma survivors.

Burgenske DM, Yang J, Decker PA, Kollmeyer TM, Kosel ML, Mladek AC, Caron AA, Vaubel RA, Gupta SK, Kitange GJ, Sicotte H, Youland RS, Remonde D, Voss JS, Fritcher EGB, Kolsky KL, Ida CM, Meyer FB, Lachance DH, Parney IJ, Kipp BR, Giannini C, Sulman EP, Jenkins RB, Eckel-Passow JE, Sarkaria JN.

Neuro Oncol. 2019 Nov 4;21(11):1458-1469. doi: 10.1093/neuonc/noz129.

PMID:
31346613
16.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218.

PMID:
25242542
17.

The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer.

Javellana M, Hoppenot C, Lengyel E.

Gynecol Oncol. 2019 Feb;152(2):228-234. doi: 10.1016/j.ygyno.2018.11.007. Epub 2018 Nov 22.

PMID:
30471899
18.

Glioblastoma multiforme with long term survival.

Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C.

Neurol India. 2005 Sep;53(3):329-32.

19.

Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.

Liu Y, Shete S, Etzel CJ, Scheurer M, Alexiou G, Armstrong G, Tsavachidis S, Liang FW, Gilbert M, Aldape K, Armstrong T, Houlston R, Hosking F, Robertson L, Xiao Y, Wiencke J, Wrensch M, Andersson U, Melin BS, Bondy M.

J Clin Oncol. 2010 May 10;28(14):2467-74. doi: 10.1200/JCO.2009.26.6213. Epub 2010 Apr 5.

20.

Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).

Grunda JM, Nabors LB, Palmer CA, Chhieng DC, Steg A, Mikkelsen T, Diasio RB, Zhang K, Allison D, Grizzle WE, Wang W, Gillespie GY, Johnson MR.

J Neurooncol. 2006 Dec;80(3):261-74. Epub 2006 Jun 14.

PMID:
16773218

Supplemental Content

Support Center